The improvecarenow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis
Presented at Digestive Disease Week 2025
, , , et al. The improvecarenow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2026; 1-10. doi:10.1002/jpn3.70370
Identifying predictors of unfavorable disease course in pediatric ulcerative colitis (UC) will impact therapeutic strategy. We aimed to define predictors of nonremission 2 years after diagnosis in pediatric patients with UC.
Symptom Profiles in Adolescents with Inflammatory Bowel Disease
Presented at Digestive Disease Week 2025
Caeli Malloy, Kendra Kamp, Kurt Kroenke, Patrick O Monahan, Susan M. Rawl, Steven Steiner, Wendy R. Trueblood Miller
Sleep disturbance, pain, anxiety, depression and fatigue are prevalent in adolescents and young adults (AYAs) with inflammatory bowel disease (IBD); pain and fatigue are two of the most common symptoms reported by both AYAs with active IBD and those in remission. Symptoms often present in co-occurring groups, known as symptom profiles. Identification of symptom profiles can inform targeted symptom management strategies and improve quality of life; however, symptom profiles have yet to be examined in AYAs with IBD.